William Pang
Directeur de la Recherche - Actions chez Capital International, Inc. (Investment Management Singapore)
Profil
William Pang is currently the Asia Research Director at Capital International, Inc. (Investment Management Singapore) since 2023.
He is also a Director at mimiX Biotherapeutics Ltd.
In the past, Mr. Pang worked as a Fund Manager & Research Analyst at Goldman Sachs Advisors BV from 2006 to 2011.
He then served as an Investment Manager at ING Investment Management Asia Pacific (Hong Kong) Ltd.
from 2011 to 2012.
Prior to his current roles, he was an Equity Analyst at Pyramis Global Advisors (Hong Kong) Ltd.
from 2012 to 2015.
Postes actifs de William Pang
| Sociétés | Poste | Début |
|---|---|---|
Capital International, Inc. (Investment Management Singapore)
 Capital International, Inc. (Investment Management Singapore) Investment ManagersFinance Capital International, Inc. (Investment Management Singapore) (Capital IM-SG) is the investment management division of Capital International, Inc., itself a subsidiary of The Capital Group Cos., Inc. in the US, a privately-owned holding company established in 1931 by Jonathan Bell Lovelace which specializes in global investment management for corporations, private individuals, foundations and endowments. Capital IM-SG is headquartered in Singapore and was founded in 1989. They are an autonomous regional investment team which shares research with the Capital Group's affiliates through centralized databases. | Directeur de la Recherche - Actions | 01/05/2023 |
Mimix Biotherapeutics Sàrl
 Mimix Biotherapeutics Sàrl BiotechnologyHealth Technology Mimix Biotherapeutics Sàrl is a private company located in Switzerland that develops and commercializes a platform to overcome limitations in tissue engineering, specifically the vascularization challenge and the need for high cell quantities. The Swiss company creates biological architectures with sound using sound-induced morphogenesis, which is a gentle, fast, and easy method to generate multi-cellular, spatially orchestrated tissue constructs using sound waves. The company offers guides for patterning parameters and cells in various hydrogels, including collagen, fibrin, gelatine, and synthetic hydrogels. The company's FastSkin® technology combines micrografting with sound-induced morphogenesis to improve wound care management, addressing a major social burden and unmet clinical need in oncology and chronic wounds treatments. Mimix Biotherapeutics also provides control over cellular and extracellular organization at high spatial resolution to investigate cell-material interactions in vitro models. | Directeur/Membre du Conseil | - |
Anciens postes connus de William Pang
| Sociétés | Poste | Fin |
|---|---|---|
ING Investment Management Asia Pacific (Hong Kong) Ltd.
 ING Investment Management Asia Pacific (Hong Kong) Ltd. Investment ManagersFinance ING Investment Management Asia Pacific (Hong Kong) Ltd. (INGIM-HK) is the wholly-owned investment management subsidiary of ING Insurance International B.V., ultimately owned by ING Groep NV (NYSE: ING). INGIM was founded in 1994 and provides asset management services to institutions, pension funds, insurance companies, fund distributors, foundations, high net-worth individuals and retail customers. They manage a range of global and regional investment products covering all asset classes. INGIM-HK was incorporated in 1997 and is the head office for the Asia Pacific region, responsible for Asian and Australasian products. The firm coordinates activities and reports to the parent group for offices in Singapore, India, Japan, the Philippines, Australia and New Zealand, Malaysia, as well as joint ventures in Thailand, Taiwan and Korea. INGIM-HK services Asian institutions, governments, and private individuals, offering active investment management capabilities and a range of mutual funds. INGIM-HK manages sub-funds of umbrella funds domiciled in Europe and the US, focusing on Asian markets. They distribute the range of funds managed within the parent group and also co-advises a global property equities fund, working in close relationship with US-based ING Clarion. | Gestionnaire de Portefeuille-Actions | 01/08/2012 |
Goldman Sachs Advisors BV
 Goldman Sachs Advisors BV Investment ManagersFinance Goldman Sachs Advisors BV (GSBV) is the wholly owned, Netherlands-based investment management subsidiary of Goldman Sachs Asset Management International Holdings BV, ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) (Goldman Sachs) in the US. Founded in 1994 as ING Investment Management Advisors BV, the firm became NNIP Advisors BV in 2015 following the IPO of NN Group. They changed their name to Goldman Sachs Advisors BV in 2023 after the acquisition of Goldman Sachs to NN Group in 2022. Headquartered in The Hague, GSBV manages a range of assets for institutional and individual clients. | Analyst-Equity | 01/01/2011 |
Pyramis Global Advisors (Hong Kong) Ltd.
 Pyramis Global Advisors (Hong Kong) Ltd. Investment ManagersFinance Pyramis Global Advisors (Hong Kong) Ltd. (Pyramis-Hong Kong) is the Hong Kong-based asset management subsidiary of Pyramis Global Advisors Holdings Corp., ultimately owned by FMR LLC in the US. A Fidelity Investments firm, Pyramis-Hong Kong was formed in 2005 to deliver asset management products and services to institutional market investors around the world. | Analyst-Equity | 01/07/2015 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
ING Investment Management Asia Pacific (Hong Kong) Ltd.
ING Investment Management Asia Pacific (Hong Kong) Ltd. Investment ManagersFinance ING Investment Management Asia Pacific (Hong Kong) Ltd. (INGIM-HK) is the wholly-owned investment management subsidiary of ING Insurance International B.V., ultimately owned by ING Groep NV (NYSE: ING). INGIM was founded in 1994 and provides asset management services to institutions, pension funds, insurance companies, fund distributors, foundations, high net-worth individuals and retail customers. They manage a range of global and regional investment products covering all asset classes. INGIM-HK was incorporated in 1997 and is the head office for the Asia Pacific region, responsible for Asian and Australasian products. The firm coordinates activities and reports to the parent group for offices in Singapore, India, Japan, the Philippines, Australia and New Zealand, Malaysia, as well as joint ventures in Thailand, Taiwan and Korea. INGIM-HK services Asian institutions, governments, and private individuals, offering active investment management capabilities and a range of mutual funds. INGIM-HK manages sub-funds of umbrella funds domiciled in Europe and the US, focusing on Asian markets. They distribute the range of funds managed within the parent group and also co-advises a global property equities fund, working in close relationship with US-based ING Clarion. | Finance |
Goldman Sachs Advisors BV
Goldman Sachs Advisors BV Investment ManagersFinance Goldman Sachs Advisors BV (GSBV) is the wholly owned, Netherlands-based investment management subsidiary of Goldman Sachs Asset Management International Holdings BV, ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) (Goldman Sachs) in the US. Founded in 1994 as ING Investment Management Advisors BV, the firm became NNIP Advisors BV in 2015 following the IPO of NN Group. They changed their name to Goldman Sachs Advisors BV in 2023 after the acquisition of Goldman Sachs to NN Group in 2022. Headquartered in The Hague, GSBV manages a range of assets for institutional and individual clients. | Finance |
Pyramis Global Advisors (Hong Kong) Ltd.
Pyramis Global Advisors (Hong Kong) Ltd. Investment ManagersFinance Pyramis Global Advisors (Hong Kong) Ltd. (Pyramis-Hong Kong) is the Hong Kong-based asset management subsidiary of Pyramis Global Advisors Holdings Corp., ultimately owned by FMR LLC in the US. A Fidelity Investments firm, Pyramis-Hong Kong was formed in 2005 to deliver asset management products and services to institutional market investors around the world. | Finance |
Capital International, Inc. (Investment Management Singapore)
Capital International, Inc. (Investment Management Singapore) Investment ManagersFinance Capital International, Inc. (Investment Management Singapore) (Capital IM-SG) is the investment management division of Capital International, Inc., itself a subsidiary of The Capital Group Cos., Inc. in the US, a privately-owned holding company established in 1931 by Jonathan Bell Lovelace which specializes in global investment management for corporations, private individuals, foundations and endowments. Capital IM-SG is headquartered in Singapore and was founded in 1989. They are an autonomous regional investment team which shares research with the Capital Group's affiliates through centralized databases. | Finance |
Mimix Biotherapeutics Sàrl
Mimix Biotherapeutics Sàrl BiotechnologyHealth Technology Mimix Biotherapeutics Sàrl is a private company located in Switzerland that develops and commercializes a platform to overcome limitations in tissue engineering, specifically the vascularization challenge and the need for high cell quantities. The Swiss company creates biological architectures with sound using sound-induced morphogenesis, which is a gentle, fast, and easy method to generate multi-cellular, spatially orchestrated tissue constructs using sound waves. The company offers guides for patterning parameters and cells in various hydrogels, including collagen, fibrin, gelatine, and synthetic hydrogels. The company's FastSkin® technology combines micrografting with sound-induced morphogenesis to improve wound care management, addressing a major social burden and unmet clinical need in oncology and chronic wounds treatments. Mimix Biotherapeutics also provides control over cellular and extracellular organization at high spatial resolution to investigate cell-material interactions in vitro models. | Health Technology |
